• 2020-12-17
    On December 16, Astellas Pharma (China) Inc. and Baheal Medical Inc. held XOSPATA® (gilteritinib) import and distribution strategic signing ceremony. This will lay the foundation for the first cooperation between the two sides in the field of imported drugs.Baheal has already partnered with Astellas before on Harnal® and Feburic® to provide health services to Chinese patients. This time, the two sides will work together again for XOSPATA enter into the Chinese market, which will fill the gap
  • 2020-11-05
    Shanghai, November 5, 2020 – Abbott and Qingdao Baheal Medical INC. formally signed an agreement in Shanghai during the Expo. Through the omni-channel commercial platform, Baheal will help high-quality products and efficient treatment programs reach patients smoothly and accurately, improve patients' experience of drug purchase and quality of life, and make good drugs benefit more patients.Jin Fangqian, general manager of Abbott's pharmaceutical business in China, and Fu Gang, chairman of Baheal
  • 2020-03-26
    Although the domestic epidemic has gradually eased, the global spread of the COVID-19 still affects the hearts of every Chinese. In order to better help control the epidemic overseas, Baheal Pharm and the World Associations of Chinese Doctors (WACD)donated masks and other anti-epidemic materials to Canada, the United States, the United Kingdom, Italy, Australia and other countries to fight the epidemic.In the early days of the epidemic, the international community provided various forms of assis
  • 2020-03-06
    On March 4, Baheal Pharm and Mylan, the world's largest generic drug supplier, reached a "screen-to-screen" cooperation on the cloud. "Baheal Pharm officially became the sole general agent of the Glucosamine Sulfate Capsules Viartril-S® (10 Capsules) in the retail market of Mylan.The close cooperation between Baheal Pharm and Mylan Pharmaceutical has a long history. With the help of Baheal Pharml's commercialization platform, Mylan's two major products of liver diseases, Subivol and Ligalon, and
  • 2020-01-11
    On January 10, Baheal Pharm and Relin Pharmaceutical , a professional academic promotion company in the ophthalmology field, reached a strategic cooperation in the retail market. Zhu Xiaowei, director of Baheal Pharmaceutical Group, vice president of Baheal Pharm, and Xia Xintao, general manager of Relin Pharmaceutical signed the agreement on behalf of both parties.
Back to Top